Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: A randomized, double-blind, placebo-controlled study

Circulation

Volumn 104, Issue 17, 2001, Pages 2012-2017

  Seiler, Christian ^a   Pohl, Tilmann ^a   Wustmann, Kerstin ^a   Hutter, Damian ^a   Nicolet, Pierre Alain ^a   Windecke, Stephan ^a   Eberli, Franz R ^a   Meier, Bernhard ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Collateral circulation; Coronary disease; Granulocyte macrophage colony stimulating factor; Growth substances

Indexed keywords

PLACEBO; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; AORTA PRESSURE; ARTICLE; BALLOON CATHETER; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; COLLATERAL CIRCULATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; GUIDE WIRE; HEART MUSCLE ISCHEMIA; HUMAN; INTRACORONARY INFUSION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035940389     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4201.097835     Document Type: Article

References (19)

1. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary disease
2. Therapeutic angiogenesis with basic fibroblast growth factor: Technique and early results
3. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion
4. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study
5. Molecular mechanisms of coronary collateral vessel growth
6. Angiogenesis and arteriogenesis: Not yet for prescription
7. Activated macrophages induce vascular proliferation
8. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb
9. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion
10. Mechanisms of angiogenesis and arteriogenesis
11. Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements
12. Adverse effects of molgramostim in marrow transplant recipients
13. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary artery bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial
14. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
15. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
16. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion
17. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury
18. Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in Watanabe heritable hyperlipidemic rabbits
19. Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris